Why J&J vaccine is paused and some good news about Moderna
01:56
Share this -
copied
Federal health officials are taking extra time to study rare blood clots potentially associated with the Johnson & Johnson Covid-19 vaccine. Meanwhile, Moderna released some good news on the long term efficacy of that company's vaccine. MSNBC Medical Contributor Dr. Nahid Bhadelia joins us to discuss.April 15, 2021
UP NEXT
'There is nothing there': Stephanie Ruhle exposes how economic insiders view Truth Social stock
11:27
'A lot will depend on how much damage was done': Brennan on next steps after Israel launches strike in Iran
07:22
High gas prices threaten Biden campaign
06:07
'The end of his quest for Manhattan's approval': How Trump's trial exposes his insecurities
10:24
Mike Johnson, on brink of losing speakership, vows not to resign
03:52
Seven jurors selected in Trump's NY criminal trial